Intra-operative intravenous fluid restriction reduces perioperative red blood cell transfusion in elective cardiac surgery, especially in transfusion-prone patients: a prospective, randomized controlled trial by unknown
RESEARCH ARTICLE Open Access
Intra-operative intravenous fluid restriction
reduces perioperative red blood cell transfusion
in elective cardiac surgery, especially in
transfusion-prone patients: a prospective,
randomized controlled trial
George Vretzakis1, Athina Kleitsaki1, Konstantinos Stamoulis1, Metaxia Bareka1, Stavroula Georgopoulou1,
Menelaos Karanikolas2*, Athanasios Giannoukas3
Abstract
Background: Cardiac surgery is a major consumer of blood products, and hemodilution increases transfusion
requirements during cardiac surgery under CPB. As intraoperative parenteral fluids contribute to hemodilution, we
evaluated the hypothesis that intraoperative fluid restriction reduces packed red-cell (PRC) use, especially in
transfusion-prone adults undergoing elective cardiac surgery.
Methods: 192 patients were randomly assigned to restrictive (group A, 100 pts), or liberal (group B, 92 pts)
intraoperative intravenous fluid administration. All operations were conducted by the same team (same surgeon
and perfusionist). After anesthesia induction, intravenous fluids were turned off in Group A (fluid restriction)
patients, who only received fluids if directed by protocol. In contrast, intravenous fluid administration was
unrestricted in group B. Transfusion decisions were made by the attending anesthesiologist, based on identical
transfusion guidelines for both groups.
Results: 137 of 192 patients received 289 PRC units in total. Age, sex, weight, height, BMI, BSA, LVEF, CPB duration
and surgery duration did not differ between groups. Fluid balance was less positive in Group A. Fewer group A
patients (62/100) required transfusion compared to group B (75/92, p < 0.04). Group A patients received fewer PRC
units (113) compared to group B (176; p < 0.0001). Intraoperatively, the number of transfused units and transfused
patients was lower in group A (31 u in 19 pts vs. 111 u in 62 pts; p < 0.001). Transfusions in ICU did not differ
significantly between groups. Transfused patients had higher age, lower weight, height, BSA and preoperative
hematocrit, but no difference in BMI or discharge hematocrit. Group B (p < 0.005) and female gender (p < 0.001)
were associated with higher transfusion probability. Logistic regression identified group and preoperative
hematocrit as significant predictors of transfusion.
Conclusions: Our data suggest that fluid restriction reduces intraoperative PRC transfusions without significantly
increasing postoperative transfusions in cardiac surgery; this effect is more pronounced in transfusion-prone
patients.
Trial registration: NCT00600704, at the United States National Institutes of Health.
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Background
Cardiac surgery is a major blood product consumer.
Data from many studies suggest that blood transfusions
are associated with increased morbidity and mortality in
cardiac surgery [1,2]. However, a recent large observa-
tional study did not show an association between mod-
erate (≤6 units) blood product exposure and reduced
long-term survival [3]. As the risk of transfusion-asso-
ciated adverse outcomes may depend on the amount of
transfusion [4], reduction of blood transfusions is con-
sidered a relevant, important goal in cardiac surgery.
During cardiac operations under CPB, two concurrent
events, namely blood loss and red blood cell dilution
due to positive fluid balance result in precipitous hema-
tocrit drop and need for allogeneic blood. Hemodilution
has been identified as a major factor influencing the
decision to transfuse. Likewise, several variables asso-
ciated with total red cell mass, such as preoperative ane-
mia, female gender and small body size, are independent
predictors of transfusion in cardiac surgery [5-8]. Exist-
ing guidelines underline the importance of limiting
hemodilution, applying blood salvage techniques and
using alternative therapies for transfusion and blood
conservation [7].
Surprisingly, data on the impact of intraoperative par-
enteral fluid restriction on transfusion needs are very
limited. Recently, we published a RCT involving 130 pts
operated for CABG under CPB supported by reinfusion
of washed shed blood from thoracic cavities, and
reported significant reduction of intraoperative PRC
transfusions with a restrictive parenteral fluid protocol
[9]. However, as only a small proportion of cardiac sur-
gery patients are “transfusion-prone” (as defined by low
preoperative hematocrit, female sex, or small BSA) our
earlier study did not have adequate power to evaluate
the role of fluid restriction on patients prone to transfu-
sion. In contrast, the present study included a higher
number of patients, and had adequate power for investi-
gating the impact of perioperative intravenous fluid
restriction on red blood cell transfusions not only in
cardiac surgery patients in general, but also in the sub-
set of patients who are considered transfusion-prone.
Methods
Patient selection and anesthesia
This prospective study was conducted in our University
Hospital over a 20-month period, after approval from
the Institution Ethics committee, and written informed
consent was obtained from all patients before entering
the study.
Inclusion criteria were elective cardiac surgery under
CPB and ages 18 - 85. Exclusion criteria were emergency
or re-do operations, operations starting after 18.00,
recent administration of TPA or other thrombolytic
medications, pre-existing hematologic disease or coagula-
tion abnormality, advanced cirrhosis, renal failure, preo-
perative blood product transfusion, combined cardiac
and carotid surgery and operations with minimal extra-
corporeal flow (surgery of ascending aorta) or circulatory
arrest.
All patients received standardized anesthesia and
intraoperative care, and were operated by the same team
(same surgeon, assistant and perfusionist) under stan-
dardized conditions (same operating room and setting)
with CPB and intra-operative cell salvage. Acute normo-
volemic hemodilution and retrograde autologous prim-
ing of the CPB circuit were not used in any patient.
Antiplatelet medications (except aspirin) were discontin-
ued at least 72 hours before surgery. Pharmacologic
agents used to decrease blood loss in cardiac surgery
(such as aprotinin, aminocaproic acid or tranexamic
acid) were not used in any patient.
Monitoring included 5-lead ECG, ST-segment analysis,
mixed venous oximetry plus continuous cardiac output
recording (Oximetry TD catheter, Edwards Lifesciences,
Germany), bispectral index (BIS/XP, Aspect Medical Sys-
tems, USA) and near-infrared spectroscopy to asses cere-
brovascular hemoglobin oxygen saturation (INVOS 5100,
Somanetics, USA).
All patients received total intravenous anesthesia with
propofol and remifentanil. Neuromuscular blockade was
maintained with cis-atracurium. The CPB pump and
tubing (Stockert SIII, Germany; circuit: Custom Pack,
Dideco, Italy) were primed with 1400 - 2000 mls of crys-
talloid, based on patient somatometric characteristics.
Anticoagulation was achieved with heparin 300 IU/kg of
body weight and ACT > 400 s was required before initi-
ating CPB. Pump flow was 2.3-2.5 liter/min/m2. All
patients received antegrade cardioplegia. Isolated CABG
patients were operated under mild passive hypothermia
down to 33.5-34.0°C, while systemic drift to 32.0°C was
applied on all other patients. The lowest bladder tem-
peratures recorded during CPB were not different
between groups (34.58 ± 0.66°C in group A vs. 34.55 ±
0.57°C in group B). Most CABG patients received one
internal mammary artery graft plus saphenous veins
grafts. Active rewarming to 37.5°C bladder temperature
and proper cardiac reperfusion were applied on all
patients. After weaning from CPB, protamine 3 mg/kg
was given to neutralize heparin. Remaining CPB circuit
blood together with blood saved from the operation
field was washed, centrifuged (Electa, Dideco, Italy) and
re-transfused. Red cell salvage continued until the
operation finished. Postoperatively all patients were
admitted to the ICU, and the same hypnotic-analgesic
regimen continued. Criteria for weaning from mechani-
cal ventilation included hemodynamic stability with
minimal or no cathecholamine support, absence of
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significant dysrhythmias, absence of major bleeding, core
body temperature > 36°C, proper level of consciousness
and acceptable blood gases with good respiratory
mechanics. Postoperative pain was controlled with intra-
venous morphine infusion. Patients transferred to the
ward when their clinical condition and laboratory find-
ings were acceptable.
Study protocol
Surgeon, assistants, perfusionist and ICU personnel were
not informed about the study. Anesthesiologists knew
there was an ongoing study, but were not informed
about the scope and aims of the study. Perfusionists fol-
lowed common guidelines for cell saver use. Patients
meeting inclusion criteria were randomly (using compu-
ter-generated numbers) allocated to either group A
(restrictive protocol) or group B (control, IV fluid
administration “as usual”, based on all available hemody-
namic data).
The following protocol was applied in group A: Intra-
venous (IV) fluids before CPB were limited to 500 ml.
Peripheral IV lines were connected to hydroxyethyl-
starch (Voluven, 6% HES 130/0.4, Fresenius Kabi,
France) and were turned off after central line placement.
However, IV fluids were given quickly (within 3-5 min-
utes) in 50 ml increments when necessary. Anesthetic
and inotropic or vasoactive solutions were double-con-
centrated and administered proximally through the cen-
tral venous line without a “carrier” fluid infusion. Blood
aspirated for sampling was re-infused and excessive line
flashing was avoided. Before CPB, hemodynamic
instability was managed according to the following algo-
rithm:
A) for MAP < 55 mmHg with SvO2 > 75%, INVOS
> 60% and BIS < 35 ⇒ titration of anesthetic drugs
[*]
B) for MAP <55 mmHg with SvO2 > 75%, INVOS >
60% and BIS > 35 ⇒ vasoconstrictor [*]
C) for SvO2 < 75%, PCWP ≥ 16 mmHg and heart
rate < 90 b/min ⇒ dobutamine
D) for SvO2 < 75% and heart rate < 40 b/min ⇒
pacing via epicardial electrode
[*] regardless of filling pressures
After applying the above corrective measures, each
anesthesiologist was free to re-evaluate the patient and
act according to his/her judgment for any other
scenario.
Patients allocated in group B, received Ringer’s Lactate
solution through their peripheral IV line; drugs were
diluted as usual and administered together with a “car-
rier” infusion at 40 ml/h. Anesthesiologists did not have
to follow any specific fluid administration protocol,
except for intraoperative PRC transfusion. Access to BIS
and INVOS data was unrestricted, and anesthesiologists
were free to manage the patient based on their judg-
ment. In both groups, peripheral tissue perfusion/oxyge-
nation was evaluated throughout the procedure, using
all available hemodynamic data, including mixed venous
oxygen saturation.
Indications for perioperative PRC transfusion
Perioperative transfusion decisions were made by the
attending anesthesiologist, based on the following hema-
tocrit-based rules: During AOX, allogeneic blood was
not given if hematocrit was >21%. For values less than
17%, one unit of PRC was transfused. When hematocrit
was between 17-21%, anesthesiologists were free to act
based on their judgment when treating group B patients.
In contrast, when treating fluid-restricted (group A)
patients, anesthesiologists were expected to take INVOS
values into consideration when deciding about transfu-
sions, as follows: If mean INVOS value from both hemi-
spheres was less than 60 or had decreased by 20% or
more, compared to mean value during pulmonary artery
catheter insertion, the patient was transfused.
In both groups, after AOX removal and before wean-
ing from CPB (usually near completion of the last proxi-
mal anastomosis or during cardiac reperfusion), PRCs
were transfused for hematocrit less than 21%. After
weaning from CPB and re-transfusion of salvaged blood,
patients were transfused for hematocrit ≤24%. In the
ICU, patients were transfused for hematocrit ≤24%,
while transfusion decisions for hematocrit values
between 24-30% were evaluated in a multimodal
manner.
Data collection and statistical analysis
Power analysis for sample size estimation was based on
the following assumptions: The total number of PRC
units transfused during hospital stay is the main out-
come. Mean value of PRC transfusions during hospital
stay is 3 units, Standard Deviation is 2 units, and redu-
cing transfusions by one PRC unit is a clinically mean-
ingful improvement compared to standard practice.
These assumptions are consistent with data from our
institution and also with published data [10]. Based on
these assumptions, the study requires 60 patients per
group, when a is set at 0.05 and power (1-b) is set at
0.8. However, we decided to enroll up to 100 patients
per group, to allow for patient attrition or missing data,
and also in order to look for differences with regards to
transfusion between patient subgroups.
Total IV fluid volume administered and urine pro-
duced before CPB, during CPB and from CPB termina-
tion to the end of surgery were recorded for each
patient. Priming and cardioplegic solution volumes,
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additional fluid given during CPB, hemofiltration
volumes and pump residual volumes were also recorded.
Hematocrit values were recorded preoperatively, after
arterial line placement, after anesthesia induction, 10
minutes after CPB started, before CPB termination, at
the end of surgery, 6 and 12 hours after ICU admission
and before discharge from the hospital. BMI and BSA
were calculated with standard formulas. Based on body
weight and gender, net erythrocyte volume loss from
the day before surgery until hospital discharge, and ery-
throcyte volume of transfused PRC units were calculated
for each patient for the entire hospitalization. Data were
stored electronically in Excel and were analyzed with
SPSS 15.0 for Windows (SPSS Inc, Chicago, IL).
Continuous data normality was tested with the Kol-
mogorov-Smirnov test (Lilliefors significant correction)
and Shapiro-Wilk test. Demographic and clinical patient
characteristics were compared between groups using
chi-square test for categorical data and Student’s two-
tailed t-test for continuous data. “Transfusion” was trea-
ted as a dichotomous variable, dividing patients in two
subgroups: those who did and those who did not receive
PRC transfusions. The association between group
assignment (fluid restriction vs. liberal fluids) and gen-
der with transfusion was evaluated with Pearson chi-
square and Fisher’s exact tests. The association of age,
weight, height, BMI, BSA, preoperative Hct and dis-
charge Hct with transfusion were tested with parametric
(independent samples T-test) and non parametric
(Mann-Whitney U) analyses. P-values < 0.05 were con-
sidered significant for all tests. Finally, a logistic regres-
sion model was constructed, to evaluate the association
of all the above variables with probability of PRC trans-
fusion using the Nagelkerke R2 and Cox & Snell R2
tests.
Results
Prospectively 192 cardiac surgery patients were ran-
domly assigned to group A (100 patients, restrictive IV
fluid administration protocol) or group B (92 patients,
liberal IV fluid administration). Baseline demographic
and clinical characteristics did not differ significantly
between groups (Table 1).
Transfusion data for the entire hospitalization are
shown in Table 1. Overall, during hospital stay 137
patients were transfused, receiving 289 units of PRCs,
and the total number of PRC units transfused was sig-
nificantly lower in group A (113 units) compared to
group B (176 units, p < 0.0001). The percentage of
patients receiving PRC transfusions was significantly
lower in group A (62 of 100 patients) compared to
group B (75 of 92 patients, p < 0.001).
Intraoperatively, 81 patients were transfused, receiving
142 units of PRCs. The number of intraoperative PRC
transfusions was significantly lower in group A (31
units) compared to group B (111 units, p < 0.0001), and
the percentage of patients receiving intraoperative trans-
fusions was significantly lower in group A (19 of 100 in
group A, vs. 62 of 92 in group B, p < 0.0001).
In the ICU, 93 patients received a total of 147 PRC
units, and the number of PRC transfusions was slightly,
Table 1 Demographic, clinical and transfusion data by
patient group
Variable Group A (fluid
restriction)
Group B (liberal fluid
administration)
Number of pts, n 100 92
Age (years) 66.0 ± 7.9 65.5 ± 8.3
Female gender, n (%) 17 (17.0%) 16 (17.4%)
Weight (kg) 77.2 ± 11.5 75.5 ± 10.6
Height (cm) 167.0 ± 7.8 168.0 ± 7.7
BMI 27.6 ± 3.5 26.7 ± 3.1
BSA (m2) 1.84 ± 0.17 1.84 ± 0.16
NYHA I-II, n (%) 57 (57.0%) 55 (59.8%)
NYHA III-IV, n (%) 43 (43.0%) 37 (40.2%)
LVEF (%) 50.2 ± 10.2 48.6 ± 12.1
Diabetes , n (%) 21 (21.0%) 20 (21.7%)
COPD, n (%) 14 (14.0%) 12 (13.0%)
Preop. Hct (%) 40.2 ± 4.42 40.6 ± 3.87
CABG, n (%) 88 (88.0%) 79 (85.9%)
Number of grafts 2.8 ± 0.6 2.7 ± 0.6
AVR + CABG 4 (4%) 4 (4.3%)
AVR 5 (5%) 6 (6.5%)
MVR 3 (3%) 2 (2.1%)
ASD Repair 0 (0%) 1 (1.1%)
CPB time (min) 96.9 ± 22.6 93.1 ± 20.0
AOX (min) 69.2 ± 20.0 67.9 ± 19.2
Operation time (min) 243 ± 49.4 236 ± 47.1
PRC transfused (total) 113 (1.13 ± 1.15*) 176 (1.91 ± 1.35) ◇◇
PRC transfused in OR,
n (mean ± SD)
31 (0.31 ± 0.71*) 111 (1.21 ± 3.15) ◇◇
PRC transfused in ICU,
n (mean ± SD)
82 (0.82 ± 0.98*) 65 (0.71 ± 0.88)
Transfused pts, n (%) 62 (62.0%) 75 (81.5%) ◇◇
Transfused pts in OR,
n (%)
19 (19.0%) 62 (67.4%) ◇◇
Transfused pts in ICU,
n (%)
51 (51.0%) 42 (45.7%)
PRC/pt transfused in OR
(mean ± SD)
1.63 ± 0.68** 1.79 ± 0.70
PRC/pt transfused in ICU
(mean ± SD)
1.61 ± 0.78** 1.55 ± 0.63
Females transfused,
n (%)
16 (94.1%) 16 (100.0%)
Pts receiving ≥ 4 PRC u
(OR + ICU)
2 (2.0%) 13 (14.1%) ◇
* denotes mean ± SD for the distribution of PRC units/pt in total
** denotes mean ± SD for the distribution of PRC units per transfused patient
◇ p < 0.001
◇◇ p < 0.0001
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but not significantly higher in group A (82 units) com-
pared to group B (65 units). Likewise, the percentage of
patients receiving transfusions in the ICU was slightly
higher in group A (51 of 100 in group A, vs. 42 of 92 in
group B), but the difference was not significant.
Table 2 presents demographic and clinical OR and
ICU data, after dividing study patients to those trans-
fused and those not transfused. Transfused patients had
significantly higher age, lower height, weight and BSA,
and lower preoperative hematocrit compared to those
not transfused, whereas BMI and discharge hematocrit
did not differ significantly. Male gender and assignment
to group A (restrictive protocol) were strongly (p <
0.003) associated with lower probability of transfusion
(Table 3).
Table 4 presents data after dividing patients within
each group, in two subgroups, based on whether they
received intraoperative PRC transfusions or not. Among
patients transfused in the OR, significant difference
existed between patients belonging in group A and B for
gender, age and BSA (Table 4). Logistic regression mod-
elling (Tables 5 &6) identified three variables as signifi-
cant predictors of transfusion: fluid administration
policy (group assignment), preoperative hematocrit and
BSA (Table 5). The model explains nearly 21.5%
(Nagelkerke R2, Table 6) of the observed variability
regarding receiving a transfusion or not, and shows that
the likelihood of PRC transfusion is 3.12 times greater
in group B compared to group A. Furthermore, each 1%
increase of preoperative hematocrit is associated with
15% (CI 5% - 26%) lower probability of transfusion.
Results concerning the number of PRC units trans-
fused per patient are displayed in Table 7 and graphi-
cally presented in Figure 1. Significantly more Group A
patients received 0 or 1 PRC unit, whereas significantly
more Group B patients received 3, 4 or more PRC units
(p < 0.0007). Statistical analysis of the association
between the two most significant parameters derived
from logistic regression (group assignment and preo-
perative hematocrit) with the number of PRCu/pt could
Table 2 Baseline demographic and clinical (OR and ICU) data on transfused (n = 137) and not transfused patients
(n = 55).
Group Statistics Independent samples tests
Transfusion Levene’s test t-test for equality of means (equal variances assumed)
mean ± SD Sig. Sig (2-tailed) Mean differ. Std error differ. 96% CI* lower/upper
Age NO 63.6 ± 9.8 0.007 0.016 -3.09 1.27 -5.59/0.58
YES 66.7 ± 7.1
Weight NO 79.3 ± 11.2 0.563 0.020 4.09 1.75 0.64/7.55
YES 75.2 ± 10.9
Height NO 171.0 ± 6.2 0.12 0.000 4.94 1.19 2.60/7.29
YES 166.1 ± 7.9
BMI NO 27.1 ± 3.2 0.442 0.745 -0.17 0.53 -1.22/0.88
YES 27.2 ± 3.4
BSA NO 1.90 ± 0.15 0.949 0.001 0.90 0.02 0.04/0.14
YES 1.81 ± 0.16
pre-op. Hct NO 42.1 ± 3.78 0.81 0.000 2.42 0.64 1.16/3.69
YES 39.6 ± 4.10
discharge Hct NO 32.8 ± 2.21 0.829 0.586 -1.19 0.35 -0.87/0.49
YES 33.0 ± 2.15
* Confidence interval of the difference
Table 3 Results of Chi-square tests evaluating the association of Transfusion with Fluid administration protocol and
Gender
Cross-tabs Chi-square tests
Transfusion Asympt. Sig. (2-sided) Exact. Sig. (2-sided) Exact. Sig. (1-sided)
NO YES
Fluid admin Restricted 38 62 0.003 Pearson chi square
Liberal 17 75 0.004 0.002 Fisher’s exact test
Gender Male 54 105 0.000 Pearson chi square
Female 1 32 0.000 0.000 Fisher’s exact test
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not reach any safe conclusions, but increased PRC u/pt
negatively correlated to the number of patients receiving
such transfusion in group A.
Table 8 shows hematocrit values for the entire obser-
vation period. Hematocrit decreased in both groups 10
minutes after CPB initiation and gradually increased
towards discharge, presenting insignificant difference
between groups at that point. Hematocrit values differed
significantly between groups in sampling 3 (p < 0.05)
and 4 (p < 0.005), but did not differ at any time during
ICU stay. Data on fluid balance are also displayed in
table 8. Only 9 of 100 group A patients received more
than 500 ml of IV fluids before CPB. For this period,
hydroxyethylstarch represented 95% of volume adminis-
tered in group A but only 50% in group B, with the rest
being crystalloid (not including saline for drug dialyses).
Fluid administered in the period before CPB differed
significantly between groups (p < 0.0001). Likewise,
between CPB initiation and the first cardioplegia admin-
istration (sampling 4), fluid balance differed significantly
between groups (p < 0.0001). Urine output and fluid
balance while on CPB [ = (pump prime + total cardio-
plegia + any other “extra” volume in the CPB machine)
- (urine + hemofiltration volume + residual CPB circuit
volume)] are also displayed. Urine output did not differ
between groups. Fluid balance for the entire procedure
was significantly lower in group A (390 ± 432) com-
pared to group B (667 ± 553, p < 0.001). Calculated net
erythrocyte volume loss during the entire procedure was
significantly lower in group A (758 ± 299 ml) compared
to group B (903 ± 303 ml, p < 0.005).
There were no OR deaths in either group. Mechanical
ventilation duration ranged from 5 to 52 hours (mean =
9.5, median = 9) in group A, and from 5 to 70 hours
(mean = 13.2, median = 10) in group B. ICU LOS ran-
ged from 1 to 10 days (mean = 2.6, median = 2) in
group A, and from 1 to 8 days (mean = 3.2, median =
2) in group B. Mechanical ventilation duration and ICU
LOS did not differ significantly between groups. Like-
wise, postoperative LOS in the ward did not differ
Table 4 Patient data, with each patient group divided in two subgroups, based on whether patients were transfused
in the operating room or not
Variable Group A (fluid restriction) Group B (liberal fluid administration)
Transfused (19 pts) Not transfused (81 pts) Transfused (62 pts) Not transfused (30 pts)
Age (yr) 70.4 ± 4.76 65.0 ± 8.15 65.5 ± 7.42 ## 63.4 ± 9.59
Females, n (%) 8 (47.0%) 9 (52.9%) 14 (87.5%) ◇◇ 2 (12.5%)
Weight (kg) 72.9 ± 12.12 78.2 ± 11.24 74.5 ± 9.30 77.4 ± 12.81
Height (cm) 160.3 ± 5.63 168.6 ± 7.38 166.5 ± 7.98 ◇ 171.0 ± 6.40
BMI 28.4 ± 4.77 27.4 ± 3.17 26.8 ± 2.83 26.4 ± 3.59
BSA (m2) 1.73 ± 0.14 1.87 ± 0.17 1.81 ± 0.15 # 1.88 ± 0.17
Preop. Hct (%) 38.4 ± 2.86 40.6 ± 4.62 39.9 ± 3.77 41.9 ± 3.79
# p < 0.05, ## p < 0.01, ◇ p < 0.001, ◇◇ p < 0.0001, when comparing transfused Group A patients vs. Transfused Group B patients.
Table 5 Variables in the Logistic Regression Equation
95% CI for EXP(B)
B S.E. Wald df Sig. Exp(B) Lower Upper
Step Group (A) -1.137 0.364 9.767 1 0.002 0.321 0.157 0.654
1a Pre-op Hct -0.139 0.046 9.107 1 0.003 0.87 0.795 0.952
BSA -2.728 1.103 6.114 1 0.013 0.065 0.008 0.568
Constant 12.320 2.571 22.957 1 0.000 224214.3
a. Variable(s) entered on step 1: BSA
SE: Standard Error, df: degrees of freedom, CI: confidence interval
Table 6 Logistic Regression model summary
Step -2 Log
likelihood




1 198.839a 0.15 0.215
a Estimation terminated at iteration number 5
Table 7 Cross-tabulation of transfused PRC units per
patient (combined OR and ICU data) by group
PRC units per patient GROUP A GROUP B TOTAL
0 38 17 55
1 26 17 43
2 25 31 56
3 9 14 23
≥4 2 13 15
TOTAL 100 92 192
Significantly more Group A patients received 0 or 1 units, whereas more
Group B patients received 3, 4, or more units (p < 0.0007).
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between groups (8.4 ± 2.2 in group A vs. 8.1 ± 2.9 in
group B). ICU complications included MI (5 pt), persis-
tent significant arrhythmia (third-degree atrioventricular
heart block, supraventricular tachyarrhythmias or symp-
tomatic ventricular arrhythmias) (8 pts), low output syn-
drome delaying extubation (6 pts) and persistent
neurological dysfunction (1 pt) in group A and MI (4
pt), arrhythmia (6 pts), low output syndrome (7 pt), and
lower extremity ischemia (1 pt) in group B. Excluding
patients with complications in the ICU, ventilation time
>24 h occurred in 5 group A patients and 6 group B
patients. Reoperation for bleeding occurred in one
group A patient who had not been transfused during
the initial operation, and one group B patient who had
already been transfused during the initial operation. In
total, re-explored patients received 4 and 6 PRC units
respectively. One patient in each group developed renal
failure and required dialysis. Finally, among patients
with complications, two group A patients (one had
CABG, one had AVR) and one group B patient (had
CABG) died in the 30-day postoperative period.
Discussion
Decisions regarding PRC transfusion are based on a
multimodal approach in cardiac surgery, and the cor-
rect, if any, transfusion trigger remains contentious. We
designed this study because we believe that fluid balance
is a modifiable variable that can impact hematocrit and
thereby influence the number of PRC units transfused.
The study demonstrated reduced intraoperative PRC
transfusion and less positive fluid balance in the
“restricted fluid” group, while hematocrit values were
not significantly different between groups at the end of
the operation. Among patients who received intraopera-
tive PRC transfusions, significantly fewer belonged to
group A. Postoperatively, the number of transfused
patients and the number of PRC units did not differ sig-
nificantly between groups.
We propose that the lower transfusion rate in group A
is attributable to our protocol, which was designed to
Table 8 Hematocrit values and fluid balance by patient
group
HEMATOCRIT VALUES Group A Group B
1. Preoperative 40.21 ± 4.42 40.57 ± 3.87
2. After arterial line placement 39.59 ± 4.72 39.04 ± 4.41
3. After anesthesia induction 37.81 ± 4.69 36.44 ± 4.03#
4. After first cardioplegia 21.26 ± 3.49 19.96 ± 3.56#
5. End of CPB 24.53 ± 3.06 24.10 ± 2.30
6. End of operation 27.23 ± 3.20 26.46 ± 2.29
7. 6 hours in the ICU 28.98 ± 3.37 28.34 ± 2.49
8. 12 hours in the ICU 30.30 ± 2.79 30.67 ± 2.60
9. Day of discharge 32.74 ± 2.22 33.13 ± 2.09
FLUID BALANCE
IV fluids (ml) to initiation of CPB 328 ± 157 642 ± 222◇◇
urine (ml) to initiation of CPB 141 ± 106 169 ± 111
fluid balance after 1st cardioplegia 2058 ± 236 2323 ± 365◇◇
urine (ml) during CPB 822 ± 483 838 ± 378
total urine production (ml) 1455 ± 532 1538 ± 546
use of filter, n (%) 11 (11.0%) 20 (21.7%)##
Overall fluid balance 390 ± 432 667 ± 553 ◇
Calculated erythrocyte volume loss 758 ± 299 903 ± 303##
# p < 0.05
## p < 0.005
◇ p < 0.001
◇ ◇ p < 0.0001
Figure 1 Number of transfused PRC units/patient. Significantly more Group A patients received 0 or 1 PRC unit, whereas significantly
more Group B patients received 3, 4, or more PRC units (p < 0.0007).
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avoid unnecessary fluid loading. Hematocrit and fluid
balance differed significantly between groups after CPB
and at the end of surgery, because group A patients
received fluids only for hypovolemia, but not to com-
pensate for vasodilatation or poor cardiac performance.
Our study showed that relatively small differences in
parenteral fluid administration can significantly influ-
ence intraoperative transfusion.
Strengths of this study include study design (prospec-
tive, randomized, adequate power). Use of a well-defined
PRC transfusion protocol and having all operations per-
formed by the same team under similar conditions
makes the study stronger, and the low number of deaths
resulted in data with few missing data points.
Study limitations include certain aspects of study design
(no formal blinding, different anesthesiologists in different
cases). Furthermore, our low mortality may reduce gener-
alizability of the results, as our conclusions may not be
applicable in cardiac surgery centers where more transfu-
sions are needed because of higher surgical complication
rates. In addition, lack of standardization with regards to
intravenous fluid administration in group B (liberal fluids)
is also a limitation. We believe that the observed difference
between groups concerning replacement solutions prob-
ably resulted from use of a carrier fluid and from “liberal”
fluid administration in group B. Unfortunately, this impor-
tant difference between groups only became obvious dur-
ing data analysis. However, we believe this important
limitation is not necessarily a major drawback because, as
group B patients received approximately 50% crystalloid
and 50% colloid, both groups overall received similar
amounts of colloid, and only differed in the amount of
crystalloids given to group B.
Despite receiving more PRC units during CPB, group
B patients had lower intraoperative Hct values (Table 8).
In addition to hemodilution from liberal fluid adminis-
tration, the observed differences between groups could
also be attributed to variability in the transfusion trigger
and variability in fluid administration during CPB
between groups: The study protocol required that Clini-
cians in Group A consider more sophisticated data like
INVOS values before initiating a blood transfusion,
whereas group B patients were transfused at the discre-
tion of the attending anaesthesiologist when Hct values
were between 17-21%. Absence of a protocol for trans-
fusion of other blood products (FFP, platelets, and cryo-
precipitate) should also be pointed out as a weakness,
because differences in treatment of coagulation abnorm-
alities could result in greater variability of blood loss,
and possibly of transfusions.
As advanced age, female gender, low BSA and preopera-
tive anemia have been identified as independent predictors
of PRC transfusion in cardiac surgery [5,7,8,11], blood loss
and CPB initiation are expected to have a greater impact
on hemoglobin concentration in these patient categories.
Patients who received transfusions in our study differed
significantly, compared to patients who were not trans-
fused with regards to these variables. Logistic regression
showed that fluid restriction is a significant factor, decreas-
ing the probability of transfusion to 0.32. Likewise, low
preoperative hematocrit was also identified as significant:
the probability of transfusion in a patient with 36% preo-
perative hematocrit is almost twice the probability of a
patient with preoperative hematocrit of 42%. Mean preo-
perative hematocrit was significantly lower in transfused
patients compared to those not transfused (Table 2). In
addition, among patients transfused in the OR, hematocrit
in group A did not differ significantly compared to group
B (Table 4). Consequently, preoperative anemia seems to
predispose to transfusion even under a fluid restriction
protocol. Subgroup analysis of our data could perhaps
help us extract clear conclusions regarding specific popu-
lation groups (e.g. low BMI patients). However, because
our study did not have adequate power for subgroup ana-
lysis, appropriately designed rigorous clinical trials are
needed to fully determine the effect of intra-operative fluid
restriction in specific population groups.
Wide variations in reported transfusion practices
[10,12] probably reflect variability between institutions,
but also indicate that transfusion decisions have a degree
of subjectivity [7,12]. It seems that we, as anesthesiolo-
gists, do not really know the degree of hemodilution that
can be tolerated by each patient. A significant proportion
of intraoperative transfusions occur during CPB, when
SVO2 monitoring is impossible, and blood samples
drawn from the venous cannula give an inconclusive pic-
ture about tissue oxygenation, because the heart is
bypassed and hemoglobin saturation values are normal-
ized by cold, less oxygen-consuming tissues. In our study,
transfusion decisions during CPB were based on hemato-
crit value, clinical condition, INVOS data, time to release
aortic clamp, temperature and urine production. We
believe that two factors influenced transfusion decisions
during this period: experience of the anesthesiologist
(interpretation of the above parameters) and protocol.
Less experienced anesthesiologists may have responded
to excessive hemodilution (more likely in group B) with
unnecessary transfusions. The strict INVOS-based proto-
col and the directions for using BIS data in group A may
have also played a role, but the true value of INVOS with
regards to transfusion decisions in cardiac surgery is
unknown. For example, we do not know how to treat a
patient with hematocrit less than 17% with normal
INVOS values during CPB. Is transfusion justified at this
point? Existing reports raise concerns regarding safety
when proceeding with low hematocrit values [13,14]. In
any case, low hematocrit values during CPB are asso-
ciated with excessive hemodilution. Finally, BIS data may
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have prompted the anesthesiologist to intervene directly
or indirectly to aspects of patient care other than hypno-
tic state depth [15].
The observed difference of calculated erythrocyte
volume loss between the two groups deserves comment,
because blood loss affects transfusion decisions. First,
this difference is difficult to explain, because the two
groups originated from randomization, had similar base-
line data, were operated under exactly the same condi-
tions, and surgery duration did not differ significantly
between groups. Second, erythrocyte volume loss calcu-
lations are based on formulas taking into account preo-
perative patient data. Consequently, because allogeneic
red cells can be displaced from the circulation earlier
than native erythrocytes, erythrocyte volume loss can be
overestimated as the number of transfused units
increases. In any case, we certainly have some reserva-
tion regarding the validity of these methods.
Outcome data, other than PRC transfusions, did not
differ significantly between groups in our study. How-
ever, this study was designed to compare PRC transfu-
sions between groups, and did not have the power to
show differences with regards to other important out-
comes, such as renal failure, length of stay, morbidity or
mortality. Because such comparisons are beyond the
size and scope of our study, we believe that convincing
answers to these important questions can only come
from well designed future studies with much larger
patient populations.
Conclusions
The results of this study show that intraoperative IV
fluid restriction combined with red cell salvage and a
well-defined PRC transfusion protocol reduces intrao-
perative PRC transfusion in cardiac surgery without sig-
nificantly increasing postoperative PRC transfusion. The
benefits of fluid restriction are more pronounced in
patients prone to transfusion (such as aged females,
patients with low BSA or low preoperative hematocrit).
Current evidence suggests that physician transfusion
practices can be improved. Consequently, appropriately
designed rigorous clinical trials are needed to confirm
the validity of our findings and determine the combined
effectiveness of new monitoring modalities and intrao-
perative fluid restriction on blood conservation, and
their role on rational decision-making regarding PRC
transfusion in cardiac surgery.
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